Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Filings indexed 875 across all filing types
Latest filing 2026-05-11 Share Issue/Capital Cha…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical acquires property portfolio with an agreed property value of SEK 845 mn from Botrygg
Share Issue/Capital Change Classification · 80% confidence The document is a press release announcing Episurf Medical’s agreement to acquire a property portfolio and detailing the financing structure, notably an issue of B-shares totalling SEK 220 mn (plus a vendor note and bank financing) and the resulting dilution. This constitutes a formal share‐issuance announcement and capital change. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-05-11 English
Episurf Medical förvärvar fastighetsportfölj med ett överenskommet fastighetsvärde om SEK 845 mn från Botrygg
M&A Activity Classification · 76% confidence The document is a formal press release by Episurf Medical AB announcing the acquisition of a diversified property portfolio from Botrygg, including deal terms, financing structure (share issuance, promissory note, bank financing), transaction rationale, and background. It is not merely a regulatory filing or summary; it is an actual announcement of a corporate transaction involving asset acquisition and related capital changes. This aligns with the M&A Activity category (TAR) for announcements related to mergers, acquisitions, or takeovers.
2026-05-11 Swedish
Regulatory Filings 2026
Regulatory Filings
2026-05-06 English
Episurf Medical has entered into letters of intent to acquire four real estate portfolios with a combined agreed property value of approximately SEK 2.6 billion
Regulatory Filings
2026-05-05 English
Episurf Medical har ingått avsiktsförklaring om förvärv av fyra fastighetsportföljer med ett sammanlagt fastighetsvärde om cirka SEK 2,6 miljarder
Regulatory Filings
2026-05-05 English
Regulatory Filings 2026
Regulatory Filings
2026-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.